SUCLA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.018000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.261600E-01
Normal-vs-Stage2
6.645400E-01
Normal-vs-Stage3
8.809000E-01
Normal-vs-Stage4
4.043000E-01
Stage1-vs-Stage2
2.232200E-01
Stage1-vs-Stage3
2.004200E-01
Stage1-vs-Stage4
7.997600E-01
Stage2-vs-Stage3
4.965400E-01
Stage2-vs-Stage4
5.004400E-01
Stage3-vs-Stage4
2.530000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.148400E-01
Normal-vs-AfricanAmerican
3.130400E-01
Normal-vs-Asian
9.949200E-01
Caucasian-vs-AfricanAmerican
3.995400E-01
Caucasian-vs-Asian
3.414000E-01
AfricanAmerican-vs-Asian
1.918000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.446000E-01
Normal-vs-Female
5.531600E-01
Male-vs-Female
5.720400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.410400E-01
Normal-vs-Age(41-60Yrs)
4.134200E-01
Normal-vs-Age(61-80Yrs)
7.278800E-01
Normal-vs-Age(81-100Yrs)
6.372000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.850600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.281000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.711400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.923700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.791600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.407200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.002600E-01
Normal-vs-Daily Drinker
9.724800E-01
Normal-vs-Weekly Drinker
9.001400E-01
Normal-vs-Occasional Drinker
3.055400E-01
Normal-vs-Social Drinker
5.802000E-01
Non Drinker-vs-Daily Drinker
7.316600E-01
Non Drinker-vs-Weekly Drinker
6.350000E-01
Non Drinker-vs-Occasional Drinker
2.861800E-02
Non Drinker-vs-Social Drinker
3.117600E-01
Daily Drinker-vs-Weekly Drinker
8.645600E-01
Daily Drinker-vs-Occasional Drinker
2.315700E-02
Daily Drinker-vs-Social Drinker
2.348800E-01
Weekly Drinker-vs-Occasional Drinker
3.762300E-02
Weekly Drinker-vs-Social Drinker
2.204400E-01
Occasional Drinker-vs-Social Drinker
5.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.142010E-01
Normal-vs-Grade 2
5.836000E-03
Normal-vs-Grade 3
1.585590E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.033800E-01
Grade 1-vs-Grade 3
4.652400E-01
Grade 1-vs-Grade 4
1.142010E-01
Grade 2-vs-Grade 3
8.930800E-01
Grade 2-vs-Grade 4
5.836000E-03
Grade 3-vs-Grade 4
1.585590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.572000E-01
Normal-vs-NonDiabetic
6.179400E-01
Diabetic-vs-NonDiabetic
3.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.809800E-01
Normal-vs-NoPancreatitis
6.260800E-01
Pancreatitis-vs-NoPancreatitis
3.216200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.681200E-01
Normal-vs-N1
6.241400E-01
N0-vs-N1
4.174200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.558200E-01
Normal-vs-TP53-NonMutant
5.941800E-01
TP53-Mutant-vs-TP53-NonMutant
8.743800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
